annb0t
Top 20
Recce Pharmaceuticals
Highlights:
Final three subjects in cohort three have been intravenously dosed; RECCE® 327 at 500mg indicating to be safe and well tolerated Milestone achieved with 10 total subjects dosed, maximizing key data set Independent Safety Committee to review final data set of third cohort and expected to clear fourth higher dose study cohort per approved protocol Cohort four recruitment underway
SYDNEY, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd...
>>> Read more: Recce Pharmaceuticals Announces Final Subjects Dosed in Third Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights:
Final three subjects in cohort three have been intravenously dosed; RECCE® 327 at 500mg indicating to be safe and well tolerated Milestone achieved with 10 total subjects dosed, maximizing key data set Independent Safety Committee to review final data set of third cohort and expected to clear fourth higher dose study cohort per approved protocol Cohort four recruitment underway
SYDNEY, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd...
>>> Read more: Recce Pharmaceuticals Announces Final Subjects Dosed in Third Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
